Back to List View Graph View

Phosphatase and Tensin Homolog (PTEN)

PTEN (Phosphatase and Tensin Homolog) is a dual-specificity tumor suppressor protein encoded by the PTEN gene on chromosome 10q23.

Where the papers sit

19 papers from the last 6 months study Phosphatase and Tensin Homolog (PTEN) directly · updated from PubMed 13 Nov 2026

Study type 0 clinical trials · 1 observational · 15 preclinical · 3 unclassified

Themes one subject · 1 new direction

Those 19 are all about one subject.

  • PTEN Disease Biology

    PTEN is examined as a regulator of AKT signaling, subcellular localization, tumor growth, vascular dysfunction, and neuronal injury. Cancer studies connect PTEN loss or pathway disruption with treatment sensitivity, radiotherapy combinations, immune resistance, and targeted drug delivery. miRNAs, exosomes, engineered cells, nanoparticles, and small-molecule inhibitors recur as ways to modify PTEN-linked disease processes. The work remains broad and exploratory, without a single dominant therapeutic direction.

    19 papers

NEW DIRECTION

PTEN nuclear translocation mediates anesthetic neurotoxicity

In aged female mice exposed repeatedly to sevoflurane, PTEN was studied as a mediator of hippocampal synaptic and cognitive injury rather than primarily as a tumor-suppressive signaling brake or a target for promoting neural regeneration. The study linked PTEN nuclear translocation to sevoflurane-associated synaptic and cognitive deficits and found that an estrogen receptor-α agonist protected against this toxicity through that PTEN-localization mechanism, extending PTEN into the control of anesthesia-induced neurodegeneration and cognitive dysfunction 42212628May.

Papers

The 19 papers from the last 6 months that study Phosphatase and Tensin Homolog (PTEN) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

PTEN Disease Biology (19)
  1. Evaluation of Murrayanine's Anticancer Potential in Breast Cancer: Integrative Computational, In Vitro, and Nanoparticle Delivery Approaches. The Journal of steroid biochemistry and molecular biology · 14 Oct 2026 PMID 42874789
  2. Phenylalanine 347 regulates the subcellular localization of PTEN. Biochemical and biophysical research communications · 3 Sept 2026 PMID 42691629
  3. Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension. Biochemical and biophysical research communications · 7 Aug 2026 PMID 42566998
  4. Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma. Cytotherapy · 6 Aug 2026 PMID 42561643
  5. Development of a 3D collagen type I hydrogel scaffold for modeling hyperglycemia-induced spinal neuronal damage and therapeutic evaluation. Histochemistry and cell biology · 30 Jul 2026 PMID 42530656
  6. Hypoxia-induced mechanism of TNBC promoting tumour cell proliferation through exosomal miRNA. Mammalian genome : official journal of the International Mammalian Genome Society · 18 Jul 2026 PMID 42471478
  7. Synthesis, in vitro and in silico studies of transition metal complexes of chrysin with potent anticancer activity via GSK3β phosphorylation, modulation of p38 MAPK pathway and HDAC8 inhibition. Bioorganic chemistry · 17 Jul 2026 PMID 42468084
  8. Analysis of PTEN Antagonistic Peptides (PAPs) in Neuronal Growth and Traumatic Brain Injury (TBI). Biomacromolecules · 10 Jul 2026 PMID 42427105
  9. PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer. The Journal of clinical investigation · 7 Jul 2026 PMID 42412555
  10. CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway. Human cell · 1 Jul 2026 PMID 42384246
  11. Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
  12. Elevated serum miR-19a-3p serves as a diagnostic and prognostic biomarker for ischemic stroke and aggravates neuronal injury by targeting PTEN. Gene · 20 Jun 2026 PMID 42323115
  13. Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer. NPJ breast cancer · 17 Jun 2026 PMID 42310300
  14. Single-ligand dual-targeting lipid nanoparticles for therapeutic mRNA delivery to glioblastoma across the blood-brain barrier. Journal of controlled release : official journal of the Controlled Release Society · 15 Jun 2026 PMID 42297114
  15. SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy. Science advances · 12 Jun 2026 PMID 42284420
  16. Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Proceedings of the National Academy of Sciences of the United States of America · 3 Jun 2026 PMID 42234523
  17. ERα Agonist Protects Aged Female Mice From Sevoflurane Neurotoxicity via PTEN Nuclear Translocation. CNS neuroscience & therapeutics · 29 May 2026 PMID 42212628
  18. Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
  19. Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939

By study type

Observational studies and case reports (1)
  1. Elevated serum miR-19a-3p serves as a diagnostic and prognostic biomarker for ischemic stroke and aggravates neuronal injury by targeting PTEN. Gene · 20 Jun 2026 PMID 42323115
Preclinical: animal, cell and lab studies (15)
  1. Phenylalanine 347 regulates the subcellular localization of PTEN. Biochemical and biophysical research communications · 3 Sept 2026 PMID 42691629
  2. Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension. Biochemical and biophysical research communications · 7 Aug 2026 PMID 42566998
  3. Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma. Cytotherapy · 6 Aug 2026 PMID 42561643
  4. Development of a 3D collagen type I hydrogel scaffold for modeling hyperglycemia-induced spinal neuronal damage and therapeutic evaluation. Histochemistry and cell biology · 30 Jul 2026 PMID 42530656
  5. Hypoxia-induced mechanism of TNBC promoting tumour cell proliferation through exosomal miRNA. Mammalian genome : official journal of the International Mammalian Genome Society · 18 Jul 2026 PMID 42471478
  6. Synthesis, in vitro and in silico studies of transition metal complexes of chrysin with potent anticancer activity via GSK3β phosphorylation, modulation of p38 MAPK pathway and HDAC8 inhibition. Bioorganic chemistry · 17 Jul 2026 PMID 42468084
  7. Analysis of PTEN Antagonistic Peptides (PAPs) in Neuronal Growth and Traumatic Brain Injury (TBI). Biomacromolecules · 10 Jul 2026 PMID 42427105
  8. PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer. The Journal of clinical investigation · 7 Jul 2026 PMID 42412555
  9. CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway. Human cell · 1 Jul 2026 PMID 42384246
  10. Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
  11. SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy. Science advances · 12 Jun 2026 PMID 42284420
  12. Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Proceedings of the National Academy of Sciences of the United States of America · 3 Jun 2026 PMID 42234523
  13. ERα Agonist Protects Aged Female Mice From Sevoflurane Neurotoxicity via PTEN Nuclear Translocation. CNS neuroscience & therapeutics · 29 May 2026 PMID 42212628
  14. Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
  15. Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
Unclassified: not yet indexed with MeSH (3)
  1. Evaluation of Murrayanine's Anticancer Potential in Breast Cancer: Integrative Computational, In Vitro, and Nanoparticle Delivery Approaches. The Journal of steroid biochemistry and molecular biology · 14 Oct 2026 PMID 42874789
  2. Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer. NPJ breast cancer · 17 Jun 2026 PMID 42310300
  3. Single-ligand dual-targeting lipid nanoparticles for therapeutic mRNA delivery to glioblastoma across the blood-brain barrier. Journal of controlled release : official journal of the Controlled Release Society · 15 Jun 2026 PMID 42297114